The Human Response to Endotoxin

[1]  M. Boes,et al.  Role of natural and immune IgM antibodies in immune responses. , 2000, Molecular immunology.

[2]  T. McIntosh,et al.  Preparation and Preclinical Evaluation of a Novel Liposomal Complete-Core Lipopolysaccharide Vaccine , 2000, Infection and Immunity.

[3]  A. Hannekum,et al.  Endotoxemia and Mediator Release During Cardiac Surgery , 2000, Angiology.

[4]  J. Parrillo,et al.  A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia , 2000, Critical Care Medicine.

[5]  K. Gardiner,et al.  Intestinal manipulation during elective aortic aneurysm surgery leads to portal endotoxaemia and mucosal barrier dysfunction. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  B. Giroir,et al.  Preoperative and postoperative endotoxemia in children with congenital heart disease. , 2000, Chest.

[7]  Z. Davis,et al.  Immunogenetic analysis of the immune response to pneumococcal polysaccharide , 2000, European journal of immunology.

[8]  J. Pittet,et al.  Spontaneous high systemic oxygen delivery increases survival rate in awake sheep during sustained endotoxemia , 2000, Critical care medicine.

[9]  M. Daha,et al.  Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies. , 2000, Glycobiology.

[10]  D. Shale,et al.  Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia , 2000, Pediatric pulmonology.

[11]  R. Zinkernagel,et al.  Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.

[12]  M. I. Halliday,et al.  Intramucosal acidosis and the inflammatory response in acute pancreatitis , 1999, American Journal of Gastroenterology.

[13]  R. Rieben,et al.  Quantitation and characterization of anti‐Galα1–3Gal antibodies in sera of 200 healthy persons , 1999, Xenotransplantation.

[14]  M. Newman,et al.  The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. , 1999, Anesthesia and analgesia.

[15]  H. Eichler,et al.  Acetaminophen has Greater Antipyretic Efficacy than Aspirin in Endotoxemia: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 1999, Clinical pharmacology and therapeutics.

[16]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[17]  S. Kaveri,et al.  Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens. , 1999, Blood.

[18]  G. Heller,et al.  Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome , 1999, Intensive Care Medicine.

[19]  H. D. Hochstein,et al.  Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. , 1999, The Journal of infectious diseases.

[20]  J. Minei,et al.  Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: Results of a multicenter phase II clinical trial , 1999 .

[21]  M. Plebani,et al.  CYTOKINES AND THE PROGRESSION OF LIVER DAMAGE IN EXPERIMENTAL BILE DUCT LIGATION , 1999 .

[22]  J. Li,et al.  Alpha-Gal oligosaccharides: chemistry and potential biomedical application. , 1999, Current medicinal chemistry.

[23]  T. Pollmächer,et al.  Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans , 1999, Inflammation Research.

[24]  Jianzhu Chen,et al.  A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.

[25]  P. Barie,et al.  Multivariate analysis of 9 disease-associated variables for outcome prediction in patients with sepsis. , 1998, Archives of surgery.

[26]  S. Calvano,et al.  The influence of human endotoxemia on CD95-induced apoptosis. , 1998, Archives of surgery.

[27]  Y. Kou,et al.  Peripheral neural modulation of endotoxin-induced hyperventilation. , 1998, Critical care medicine.

[28]  J. Goldberg,et al.  The Phosphorylcholine Epitope Undergoes Phase Variation on a 43-Kilodalton Protein in Pseudomonas aeruginosa and on Pili of Neisseria meningitidis and Neisseria gonorrhoeae , 1998, Infection and Immunity.

[29]  G. Ramsay,et al.  Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra‐abdominal sepsis , 1998, The British journal of surgery.

[30]  Jianzhu Chen,et al.  Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. , 1998, Journal of immunology.

[31]  F. Clubb,et al.  Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. , 1998, Circulation.

[32]  D. Gouma,et al.  Peritoneal cytokine release after elective gastrointestinal surgery and postoperative complications. , 1998, American journal of surgery.

[33]  D Eisenberg,et al.  The BPI/LBP family of proteins: A structural analysis of conserved regions , 1998, Protein science : a publication of the Protein Society.

[34]  J. Reynolds,et al.  Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis , 1998, Gut.

[35]  P. Elsbach,et al.  Role of the bactericidal/permeability-increasing protein in host defence. , 1998, Current opinion in immunology.

[36]  B. Giroir,et al.  Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis , 1997, The Lancet.

[37]  Wiklund Ra,et al.  First of two parts , 1997 .

[38]  K. Khabar,et al.  Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. , 1997, Clinical immunology and immunopathology.

[39]  G. Beck,et al.  ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting. , 1997, The Annals of thoracic surgery.

[40]  H. Zola,et al.  Blood group antibodies are made by CD5+ and by CD5− B cells , 1997, Immunology and cell biology.

[41]  M. Fenton,et al.  IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. , 1997, Journal of immunology.

[42]  S. Leng,et al.  Interleukin-11 inhibits macrophage interleukin-12 production. , 1997, Journal of immunology.

[43]  S. Deventer,et al.  Modulation of Cytokine Release and Neutrophil Function by Granulocyte Colony-Stimulating Factor During Endotoxemia in Humans , 1997 .

[44]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[45]  F. Rosen,et al.  Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. , 1997, Journal of immunology.

[46]  A. Baue.  Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? , 1997, Archives of surgery.

[47]  M. Davies,et al.  Systemic inflammatory response syndrome , 1997, The British journal of surgery.

[48]  A. Coutinho,et al.  The repertoire of serum IgM in normal mice is largely independent of external antigenic contact , 1997, European journal of immunology.

[49]  M. Seidelmann,et al.  TIME‐SCALE OF INTERLEUKIN‐6, MYELOID RELATED PROTEINS (MRP), C REACTIVE PROTEIN (CRP), AND ENDOTOXIN PLASMA LEVELS DURING THE POSTOPERATIVE ACUTE PHASE REACTION , 1997, Shock.

[50]  D. Nieman.  Immune response to heavy exertion. , 1997, Journal of applied physiology.

[51]  T. van der Poll,et al.  Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. , 1997, Journal of immunology.

[52]  D. Tarragó,et al.  Human Polyreactive IgM Monoclonal Antibodies with Blocking Activity Against Self‐Reactive IgG , 1997, Scandinavian journal of immunology.

[53]  W. White,et al.  Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. , 1997, JAMA.

[54]  L. Herzenberg,et al.  An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. , 1997, Journal of immunology.

[55]  N. Cheshire,et al.  Endotoxin related early neutrophil activation is associated with outcome after thoracoabdominal aortic aneurysm repair , 1997, The British journal of surgery.

[56]  S. Cryz,et al.  Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. , 1997, Behring Institute Mitteilungen.

[57]  M. Delgado-Rodríguez,et al.  Total Cholesterol, HDL-Cholesterol, and Risk of Nosocomial Infection: A Prospective Study in Surgical Patients , 1997, Infection Control & Hospital Epidemiology.

[58]  J. Kremer,et al.  Transforming Growth Factor-β1 Inhibits Synthesis of Cytokines in Endotoxin-Stimulated Human Whole Blood , 1996 .

[59]  J. E. Doran,et al.  Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia , 1996, The Journal of experimental medicine.

[60]  A. Coutinho,et al.  The Self‐Reactive Antibody Repertoire of Normal Human Serum IgM is Acquired in Early Childhood and Remains Conserved Throughout Life , 1996, Scandinavian journal of immunology.

[61]  G. Barclay,et al.  Passive Immunisation with IgG Endotoxin Core Antibody Hyperimmune Fresh Frozen Plasma , 1996, Vox sanguinis.

[62]  P. Potgieter,et al.  The Influence of Surgery on Cytokines in Patients with Intra-Abdominal Sepsis , 1996, Anaesthesia and intensive care.

[63]  T. van der Poll,et al.  Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor. , 1996, Journal of immunology.

[64]  J. Bion,et al.  Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. , 1996, JAMA.

[65]  T. Pollmächer,et al.  Influence of endotoxin on daytime sleep in humans , 1996, Infection and immunity.

[66]  P. Barie,et al.  Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. , 1996, Archives of surgery.

[67]  F. Stüber,et al.  A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. , 1996, Critical care medicine.

[68]  G. Tytgat,et al.  Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients. , 1996, Journal of cardiothoracic and vascular anesthesia.

[69]  P. Myles,et al.  The association among gastric mucosal pH, endotoxemia, and low systemic vascular resistance after cardiopulmonary bypass. , 1996, Journal of cardiothoracic and vascular anesthesia.

[70]  F. Holsboer,et al.  Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. , 1996, Blood.

[71]  J. Platt,et al.  Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies. , 1996, Human immunology.

[72]  T. van der Poll,et al.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.

[73]  R. Colman,et al.  Cofactors V and VIII after endotoxin administration to human volunteers. , 1995, Thrombosis research.

[74]  S. Banks,et al.  Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. , 1995, Journal of immunology.

[75]  I. Poxton.  Antibodies to lipopolysaccharide. , 1995, Journal of immunological methods.

[76]  T. van der Poll,et al.  Endotoxin induces downregulation of tumor necrosis factor receptors on circulating monocytes and granulocytes in humans. , 1995, Blood.

[77]  R. Rieben,et al.  IN VITRO EVALUATION OF THE EFFICACY AND BIOCOMPATIBILITY OF NEW, SYNTHETIC ABO IMMUNOABSORBENTS , 1995, Transplantation.

[78]  M. Boermeester,et al.  Effect of hypertriglyceridemia on endotoxin responsiveness in humans , 1995, Infection and immunity.

[79]  A. Hannekum,et al.  New aspects concerning the regulation of the post-operative acute phase reaction during cardiac surgery. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[80]  P D Marsh,et al.  Age-related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individuals. , 1995, Oral microbiology and immunology.

[81]  G. Ramsay,et al.  Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. , 1995, JAMA.

[82]  A. Eerenberg,et al.  Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. , 1995, The Journal of infectious diseases.

[83]  M. Seidelmann,et al.  Incidence and pathophysiological relevance of postoperative endotoxemia. , 1995, FEMS immunology and medical microbiology.

[84]  J. T. ten Cate,et al.  Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23). , 1995, Blood.

[85]  L. Kinzl,et al.  Endotoxemia and specific antibody behavior against different endotoxins following multiple injuries. , 1995, The Journal of trauma.

[86]  M. Wurfel,et al.  Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein , 1995, The Journal of experimental medicine.

[87]  K. Feingold,et al.  Role for circulating lipoproteins in protection from endotoxin toxicity , 1995, Infection and immunity.

[88]  A. Coutinho,et al.  Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[89]  F. Stentz,et al.  Clinical Investigations in Critical CarePersistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS: Plasma IL-1β and IL-6 Levels Are Consistent and Efficient Predictors of Outcome Over Time , 1995 .

[90]  S. Lowry,et al.  An overview of mortality risk prediction in sepsis. , 1995, Critical care medicine.

[91]  S. Calvano,et al.  Influence of IL-1 receptor blockade on the human response to endotoxemia. , 1995, Journal of immunology.

[92]  R. D. de Winter,et al.  Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans. , 1995, Journal of inflammation.

[93]  W. Hogge,et al.  Determination of normal human fetal immunoglobulin M levels , 1995, Clinical and diagnostic laboratory immunology.

[94]  C. McClain,et al.  Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. , 1994, The Journal of clinical investigation.

[95]  M. Ohlin,et al.  Enhanced ELISA sensitivity using TCA for efficient coating of biologically active lipopolysaccharides or lipid A to the solid phase. , 1994, Journal of immunological methods.

[96]  T. van der Poll,et al.  Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees , 1994, The Journal of experimental medicine.

[97]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS , 1994, The Journal of experimental medicine.

[98]  M. I. Halliday,et al.  Bowel ischaemia and organ impairment in elective abdominal aortic aneurysm repair , 1994, The British journal of surgery.

[99]  I. Mattsby‐Baltzer,et al.  Endotoxin is angiogenic. , 1994, International journal of experimental pathology.

[100]  W. Shoemaker,et al.  Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury , 1994, Critical care medicine.

[101]  W. Buurman,et al.  Slow release of soluble TNF receptors by monocytes in vitro. , 1994, Journal of immunology.

[102]  A. Eerenberg,et al.  Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees , 1994, The Journal of experimental medicine.

[103]  J. Devière,et al.  Interleukin-10 production during septicaemia , 1994, The Lancet.

[104]  A. Weintraub,et al.  Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence. , 1994, Microbial pathogenesis.

[105]  H. D. Hochstein,et al.  Properties of US Standard Endotoxin (EC-5) in human male volunteers , 1994 .

[106]  T. van der Poll,et al.  Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia. , 1994, The Journal of infectious diseases.

[107]  P. Barie,et al.  Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. , 1994, Journal of the American College of Surgeons.

[108]  G. Barclay,et al.  Antibodies to endotoxin core in sudden infant death syndrome. , 1994, Archives of disease in childhood.

[109]  T. van der Poll,et al.  Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. , 1994, Blood.

[110]  J. Lam,et al.  Appropriate coating methods and other conditions for enzyme-linked immunosorbent assay of smooth, rough, and neutral lipopolysaccharides of Pseudomonas aeruginosa , 1994, Clinical and diagnostic laboratory immunology.

[111]  A. Walsh,et al.  In vivo protection against endotoxin by plasma high density lipoprotein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[112]  M. Sandrin,et al.  Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[113]  B. Appelmelk,et al.  Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins. , 1993, Journal of general microbiology.

[114]  P. Merino,et al.  Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? , 1993, Critical care medicine.

[115]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[116]  C. Haslett,et al.  Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators , 1993, Journal of leukocyte biology.

[117]  D. Dunn,et al.  Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms. , 1993, Annals of surgery.

[118]  G. Ramsay,et al.  A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides , 1993, Infection and immunity.

[119]  D. Powars,et al.  Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[120]  L. Moldawer,et al.  Cachexia and the acute‐phase protein response in inflammation are regulated by interleukin‐6 , 1993, European journal of immunology.

[121]  J. Windsor,et al.  Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis , 1993, The British journal of surgery.

[122]  A. Webb,et al.  The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[123]  R. Colman,et al.  Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. , 1993, Blood.

[124]  R. Danner,et al.  Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. , 1993, The New England journal of medicine.

[125]  M. Lamy,et al.  Sequential Anti‐core Glycolipid Immunoglobulin Antibody Activities in Patients With and Without Septic Shock and Their Relation to Outcome , 1993, Annals of surgery.

[126]  S. Calvano,et al.  Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. , 1993, Journal of immunology.

[127]  L. W. Andersen,et al.  Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor‐α concentrations in patients undergoing cardiopulmonary bypass , 1993, Critical care medicine.

[128]  C. Dinarello,et al.  Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. , 1993, Archives of surgery.

[129]  W. Fiers,et al.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia , 1993, The Journal of experimental medicine.

[130]  C. S. Raymond,et al.  Anti-endotoxin monoclonal antibodies protect by enhancing bacterial and endotoxin clearance. , 1993, Archives of surgery.

[131]  M. Wiles,et al.  Evolution of vertebrate IgM: complete amino acid sequence of the constant region of Ambystoma mexicanum μ chain deduced from cDNA sequence , 1992, European journal of immunology.

[132]  Z. Sheng,et al.  The role of endotoxin in the pathogenesis of experimental multiple system organ failure: a preliminary report. , 1992, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[133]  T. Yokochi,et al.  Detection of lipopolysaccharide (LPS) and identification of its serotype by an enzyme-linked immunosorbent assay (ELISA) using poly-L-lysine. , 1992, Journal of immunological methods.

[134]  R. Rieben,et al.  Naturally occurring ABO antibodies: Long‐term stable, individually distinct anti‐A IgG spectrotypes , 1992, European journal of immunology.

[135]  L. Moldawer,et al.  Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans. , 1992, Surgery.

[136]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[137]  L. Moldawer,et al.  Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[138]  J. Shelhamer,et al.  Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans. , 1992, The American review of respiratory disease.

[139]  J. E. Carceller.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[140]  K. Yamauchi,et al.  Identification of the bactericidal domain of lactoferrin. , 1992, Biochimica et biophysica acta.

[141]  C. Starnes.  Coley's toxins in perspective , 1992, Nature.

[142]  G. Beck,et al.  Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. , 1992, JAMA.

[143]  L. Moldawer,et al.  Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. , 1992, Blood.

[144]  M. Weil,et al.  Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. , 1992, The Journal of laboratory and clinical medicine.

[145]  J. Griffiss,et al.  Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. , 1992, The Journal of clinical investigation.

[146]  C. Chopin,et al.  Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. , 1992, Chest.

[147]  D. Wallach,et al.  Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors , 1992, The Journal of experimental medicine.

[148]  C. Dinarello,et al.  Production of interleukin-1-receptor antagonist during experimental endotoxaemia , 1991, The Lancet.

[149]  R. Genco,et al.  Humoral immunity of older adults with periodontal disease to Porphyromonas gingivalis , 1991, Infection and immunity.

[150]  R. Rieben,et al.  Antibodies to histo‐blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories , 1991, Transfusion.

[151]  C. Slaughter,et al.  Expression and characterization of recombinant human acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides. , 1991, Biochemistry.

[152]  H. Köhler,et al.  Human anti-phosphorylcholine antibodies share idiotopes and are self-binding. , 1991, The Journal of clinical investigation.

[153]  L. Moldawer,et al.  IL-8 in septic shock, endotoxemia, and after IL-1 administration. , 1991, Journal of immunology.

[154]  A. Mackensen,et al.  Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. , 1991, Cancer research.

[155]  S. Avrameas,et al.  Ig repertoire of human polyspecific antibodies and B cell ontogeny. , 1991, Journal of immunology.

[156]  M. Weil,et al.  Monophosphoryl lipid A induces tolerance to the lethal hemodynamic effects of endotoxemia. , 1991, Circulatory shock.

[157]  H. Büller,et al.  Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways , 1990 .

[158]  R. Munford,et al.  Deacylation of structurally diverse lipopolysaccharides by human acyloxyacyl hydrolase. , 1990, The Journal of biological chemistry.

[159]  R. Ulevitch,et al.  Structure and function of lipopolysaccharide binding protein. , 1990, Science.

[160]  S. Jackson,et al.  Serum immunoglobulins to endotoxin core glycolipid: acute leukaemia and other cancers. , 1990, Archives of disease in childhood.

[161]  A C Allison,et al.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. , 1990, The Journal of clinical investigation.

[162]  G. Barclay,et al.  IgG antibodies to gram-negative endotoxin in human sera. II. Opsonic activity of cross-reactive antibodies to endotoxin core for rough and smooth bacteria , 1990 .

[163]  David G. E. Smith,et al.  IgG Antibodies to Gram-negative endotoxin in human sera. I. Lipopolysaccharide (LPS) cross-reactivity due to antibodies to LPS core , 1990 .

[164]  M. N. Marra,et al.  Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. , 1990, Journal of immunology.

[165]  T. Zagulski,et al.  Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. , 1989, British journal of experimental pathology.

[166]  R. Munford,et al.  Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides. , 1989, The Journal of biological chemistry.

[167]  O. Ramilo,et al.  Specific detection of Haemophilus influenzae type b lipooligosaccharide by a polymyxin B monoclonal antibody assay. , 1989, Journal of immunological methods.

[168]  J. Kovacs,et al.  The cardiovascular response of normal humans to the administration of endotoxin. , 1989, The New England journal of medicine.

[169]  K. Tracey,et al.  Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. , 1989, Annals of surgery.

[170]  E. Gullichsen,et al.  Renal oxygenation in endotoxin shock in dogs. , 1989, Critical care medicine.

[171]  A. Bernstein,et al.  A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. , 1989, Circulation.

[172]  J. Parrillo,et al.  Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. , 1989, The New England journal of medicine.

[173]  G. Csako,et al.  Response of humans to gamma-irradiated reference Escherichia coli endotoxin. , 1989, Journal of clinical & laboratory immunology.

[174]  J. Harvey,et al.  Antibody to endotoxin is associated with decreased frequency of postoperative infection. , 1989, American journal of obstetrics and gynecology.

[175]  P. Brandtzaeg,et al.  Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. , 1989, The Journal of infectious diseases.

[176]  M. Andersson,et al.  Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity. , 1989, Carbohydrate research.

[177]  Romeiser Ah,et al.  Abdominal aortic aneurysm repair. , 1988, IMJ. Illinois medical journal.

[178]  W. R. Mccabe,et al.  Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects. , 1988, The Journal of infectious diseases.

[179]  J. Griffiss,et al.  Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora , 1988, Infection and immunity.

[180]  J. Mcghee,et al.  Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies. , 1988, Clinical and experimental immunology.

[181]  D. Wilmore,et al.  A single dose of endotoxin activates neutrophils without activating complement. , 1987, Surgery.

[182]  G. Barclay,et al.  Endotoxin‐Polymyxin Complexes in an Improved Enzyme‐Linked Immunosorbent Assay for IgG Antibodies in Blood Donor Sera to Gram‐Negative Endotoxin Core Glycolipids , 1987, Vox sanguinis.

[183]  S. Shohet,et al.  The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies , 1987, The Journal of experimental medicine.

[184]  S. Shohet,et al.  Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[185]  E. Draper,et al.  Prognosis in Acute Organ‐System Failure , 1985, Annals of surgery.

[186]  R. Freeman,et al.  Prevention of fever and gram negative infection after open heart surgery by antiendotoxin. , 1985, Thorax.

[187]  J. McCutchan,et al.  PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID , 1985, The Lancet.

[188]  R. Freeman,et al.  Rises in antibody to enteric gram negative bacilli after open heart surgery: a possible mechanism for postoperative pyrexia. , 1985, Thorax.

[189]  A. Coutinho,et al.  High frequency of natural autoantibodies in normal newborn mice. , 1985, Journal of immunology.

[190]  K. Tanamoto,et al.  Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate , 1984, Infection and immunity.

[191]  M. Rittenberg,et al.  Subpopulations of antibodies to phosphocholine in human serum. , 1984, Journal of immunology.

[192]  L. S. Young,et al.  Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. , 1983, The Journal of clinical investigation.

[193]  D. Briles,et al.  Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine , 1983, Journal of clinical microbiology.

[194]  鈴木 益子,et al.  Limulus Amoebocyte Lysateゲル化反応 , 1982 .

[195]  F. Audibert,et al.  Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. , 1981, The Journal of infectious diseases.

[196]  D. Briles,et al.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae , 1981, The Journal of experimental medicine.

[197]  R. Ulevitch,et al.  New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. , 1979, The Journal of clinical investigation.

[198]  J. Smyth,et al.  Progress in Clinical and Biological Research , 1979 .

[199]  M. Yadav,et al.  Maternal and cord serum immunoglobulins in four Malaysian races. , 1977, Singapore medical journal.

[200]  L. Young,et al.  Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae. , 1977, The Journal of infectious diseases.

[201]  N. Kochibe,et al.  Immunochemical Studies on Bacterial Blood Group Substances , 1972 .

[202]  G. Springer,et al.  Blood group isoantibody stimulation in man by feeding blood group-active bacteria. , 1969, The Journal of clinical investigation.

[203]  T. Hartley,et al.  Quantitation of IgA and IgM in umbilical cord serum of normal newborn infants. , 1969, The Journal of pediatrics.

[204]  N. Kochibe,et al.  [Immunochemical studies on bacterial blood group substances. V. Structures of B determinant groups]. , 1968, Japanese journal of microbiology.

[205]  E. Kabat,et al.  Immunochemical studies on blood groups. XXIII. Studies on the cross reactivity of untreated and partially hydrolyzed blood group A, B and O(H) substances with type XIV antipneumococcal horse sera. , 1959, Journal of immunology.

[206]  E. Neter,et al.  Studies of enterobacterial lipopolysaccharides; effects of heat and chemicals on erythrocyte-modifying, antigenic, toxic and pyrogenic properties. , 1956, Journal of immunology.

[207]  N. K. Jerne,et al.  THE NATURAL-SELECTION THEORY OF ANTIBODY FORMATION. , 1955, Proceedings of the National Academy of Sciences of the United States of America.

[208]  E. Kabat,et al.  IMMUNOCHEMICAL STUDIES ON BLOOD GROUPS , 1946, The Journal of experimental medicine.

[209]  M. Eaman.  Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[210]  J. S. Smith,et al.  Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: results of a multicenter phase II clinical trial. rBPI21 Acute Hemorrhagic Trauma Study Group. , 1999, Journal of Trauma.

[211]  G. Palomaki,et al.  Reference distributions for immunoglobulins A, G, and M: A practical, simple, and clinically relevant approach in a large cohort , 1998, Journal of clinical laboratory analysis.

[212]  M. Daha,et al.  Specificity of monoclonal antibodies against ABH and related structures tested by ELISA with synthetic glycoconjugates. , 1997, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[213]  J. Stavnezer.  Antibody class switching. , 1996, Advances in immunology.

[214]  E. Moore,et al.  Interleukin-6 delays neutrophil apoptosis. , 1996, Archives of surgery.

[215]  T. van der Poll,et al.  Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? , 1995, Shock.

[216]  W. Alvord,et al.  Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. , 1995, The Journal of infectious diseases.

[217]  J. Levin.  Bacterial endotoxins: lipopolysaccharides from genes to therapy: proceedings of the third conference of the International Endotoxin Society, held in Helsinki, Finland, on August 15-18, 1994 , 1995 .

[218]  H. Tilg,et al.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.

[219]  T. van der Poll,et al.  Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. , 1994, The Journal of clinical investigation.

[220]  Z. Ba,et al.  Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. , 1991, The American journal of physiology.

[221]  Miller Rd,et al.  Antibodies to core lipid fractions of endotoxin in children with rheumatic disease. , 1991 .

[222]  R. Ulevitch,et al.  Regulatory mechanisms of host responsiveness to endotoxin (lipopolysaccharide). , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[223]  Thijs Lg,et al.  Endotoxin-induced neutrophil activation--the role of complement revisited. , 1991 .

[224]  C. Dinarello,et al.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.

[225]  D. Briles,et al.  High anti-phosphorylcholine antibody levels and mortality associated with pneumonia. , 1990, Scandinavian journal of infectious diseases.

[226]  D. Briles,et al.  Age-related change in anti-carbohydrate antibody levels. , 1989, American journal of epidemiology.

[227]  A. Fomsgaard,et al.  Preliminary study on treatment of septic shock patients with antilipopolysaccharide IgG from blood donors. , 1989, Scandinavian journal of infectious diseases.

[228]  L. W. Andersen,et al.  Presence of circulating endotoxins during cardiac operations. , 1987, The Journal of thoracic and cardiovascular surgery.

[229]  W. M. Gardiner,et al.  Systemic and regional hemodynamic changes after intraperitoneal endotoxin in rabbits: development of a new model of the clinical syndrome of hyperdynamic sepsis. , 1987, Circulatory shock.

[230]  B. Appelmelk,et al.  An enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies to different parts of the gram-negative lipopolysaccharide core region. , 1985, Journal of immunological methods.

[231]  M. Salmon,et al.  The significance of IgM antinuclear antinuclear antibody in rheumatoid arthritis and other connective tissue diseases. , 1984, Rheumatology international.

[232]  H. D. Hochstein,et al.  The processing and collaborative assay of a reference endotoxin. , 1983, Journal of biological standardization.

[233]  Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins , 2022 .